HSCYX | VISGX | HSCYX / VISGX | |
Total Expense Ratio | 0.99 | 0.19 | 521% |
Annual Report Gross Expense Ratio | 0.99 | 0.19 | 521% |
Fund Existence | 29 years | 27 years | - |
Gain YTD | 2.791 | 3.860 | 72% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 3000 | 8,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 605M | 37.5B | 2% |
Annual Yield % from dividends | 0.00 | 0.42 | - |
Returns for 1 year | 3.54 | 11.58 | 31% |
Returns for 3 years | 24.60 | 32.52 | 76% |
Returns for 5 years | -6.87 | 33.61 | -20% |
Returns for 10 years | 22.86 | 134.79 | 17% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PBE | 68.46 | 0.60 | +0.88% |
Invesco Biotechnology & Genome ETF | |||
IVW | 115.59 | 0.14 | +0.12% |
iShares S&P 500 Growth ETF | |||
XCNY | 26.33 | N/A | N/A |
SPDR S&P Emerging Markets ex-China ETF | |||
JPMB | 39.51 | -0.05 | -0.13% |
JPMorgan USD Emerging Mkts Svr Bd ETF | |||
FLGB | 31.96 | -0.13 | -0.41% |
Franklin FTSE United Kingdom ETF |